PK

Prameela Koona

Active Director Director DIN 11331635
DIN 11331635 First appointment Sep 2025 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Prameela Koona

Data last updated:

Prameela Koona is a Director at Lorgov Pharmaceuticals Private Limited (since 2025). The company operates in Chemicals. Lorgov Pharmaceuticals Private Limited reported revenue of ₹25.3 Lakh (FY 2025).

DIN 11331635
Primary Designation Director
Industry Chemicals
First Appointment 30 Sep 2025
Oldest Company Age 5 yrs
Largest company Lorgov Pharmaceuticals Private Limited · ₹25.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20252021₹25.3 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Lorgov Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Prameela Koona

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prameela Koona

Prameela Koona currently holds 1 directorship: Lorgov Pharmaceuticals Private Limited (Director, since 30 Sep 2025, revenue ₹25.3 Lakh (FY 2025)).

Prameela Koona was first appointed on 30 Sep 2025 as Director at Lorgov Pharmaceuticals Private Limited.

The current boards of Prameela Koona's companies include Deepthi Allamsetty (Lorgov Pharmaceuticals Private Limited), Pujitha Sandula (Lorgov Pharmaceuticals Private Limited), Sireesha Jallepalli (Lorgov Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available